Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT00024102

Completed

Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer

Breast Cancer
NCT02037269

Completed

LightPathTM Imaging System for Ex-vivo Assessment of Margin and Lymph Node Status in Breast Cancer Surgical Specimens

Breast Cancer
NCT00161265

Completed

Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer

Breast Cancer
NCT02846428

Completed

To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer

Breast Cancer
NCT02842099

Unknown

Standard Chemotherapy Followed by Capecitabine as Prolonged Postoperative Adjuvant Treatment for Breast Cancer

Breast Cancer
NCT02838238

Unknown

X Versus Placebo as Postoperative Adjuvant Treatment for Elder Breast Cancer

Breast Cancer
NCT01256528

Completed

Delayed-Delayed Breast Reconstruction

Breast Cancer
NCT00516698

Completed

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer

Breast Cancer
NCT01346579

Terminated

Biomarkers in Tissue Samples From Older Women With Breast Cancer

Breast Cancer
NCT02817334

Unknown

A Prospective Clinical Study for Evaluation of Safe Resection Margin in Breast Conserving Surgery in Breast Cancer

Breast Cancer
NCT02802826

Unknown

Studying Tailored Exercise Prescriptions in Breast Cancer Patients (STEPS)

Breast Cancer
NCT02790580

Unknown

Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib in Breast Cancer Patients

Breast Cancer
NCT00579800

Completed

Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation

Breast Cancer
NCT02766530

Unknown

Integrated Positron Emission Tomography Magnetic Resonance (PET/MR) of Breast Cancer

Breast Cancer
NCT00567879

Terminated

A Trial of Panobinostat and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer (MBC) Whose Disease Has Progressed on or After Trastuzumab

Breast Cancer
NCT00156130

Completed

Accelerated Radiotherapy Outcomes in Women

Breast Cancer
NCT02658461

Completed

An Observational Time and Motion Study of Trastuzumab Subcutaneous (SC) and Intravenous (IV) Formulations in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (EBC)

Breast Cancer
NCT00338247

Approved for marketing

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Neoplasms, Breast
NCT02597868

Unknown

A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)

Breast Cancer
NCT00568022

Completed

A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer

Breast Cancer
NCT00084539

Completed

Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer

Breast Cancer
NCT00320385

Completed

Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer

Neoplasms, Breast
NCT00534755

Completed

Prospective & Retrospective Data Collection of Breast Cancer Cases From 2000 to Present

Breast Cancer
NCT02580799

Completed

Study of Human Epidermal Growth Receptor (HER2) Status Evaluation in Breast Cancer Pathology Samples

Breast Cancer
NCT00917735

Completed

Green Tea and Reduction of Breast Cancer Risk

Breast Cancer
NCT00544232

Completed

Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)

Breast Cancer
NCT00666822

Completed

Compliance to a Hormone Therapy Regimen in Breast Cancer

Breast Cancer
NCT01972984

Completed

Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer Patients (NEO ER 11-05)

Breast Cancer
NCT01048099

Completed

Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer

Breast Cancer
NCT00214292

Completed

Evaluation of Breast Cancer Surgical Margins Using Optical Spectroscopy

Breast Cancer
NCT00461253

Completed

Case-Control-Study on the Breast Cancer Risk of Mirena® Compared With Copper IUDs

Breast Cancer
NCT00681122

Completed

CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily Practice Through Educational Approach) (CARIATIDE)

Breast Cancer
NCT02654444

Completed

Semi-Quantification of Her2/Neu Protein Expression in Formalin Fixed, Paraffin-Embedded Normal and Neoplastic Tissue

Breast Cancer
NCT01304251

Completed

Effects of Short-term Fasting on Tolerance to Chemotherapy

Breast Cancer
NCT02023359

Completed

Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast Cancer

Breast Cancer
NCT01634984

Unknown

The Diagnostic Technology Applied Research of CDK5RAP2 in Breast Cancer

Breast Cancer
NCT00535509

Completed

Phase II Trial of Neoadjuvant[FEC100]/Cisplatin-Docetaxel ± Trastuzumab in Women With Over Expressed or Amplified Her2/Neu With Locally Advanced Breast Cancer

Breast Cancer
NCT01400399

Unknown

Cosmetic Evaluation of Lumpectomy Versus Oncolytic Mammoplasty With Bilateral Breast Reduction for Early Stage Breast Cancer

Breast Carcinoma
NCT01819324

Completed

A Lifestyle Intervention for Breast Cancer Survivors (TTMI)

Breast Cancer
NCT02617264

Unknown

Spot tm Tattooing of Biopsied Axillary Lymph Nodes With Ultrasound Guided in Breast Cancer Patients Prior to Surgery

Breast Cancer
NCT02596724

Unknown

TME Neoadjuvant Breast Registry

Breast Cancer | Breast Neoplasms
NCT01542216

Withdrawn

Evaluation of Nutrition and Metabolism in Breast Cancer Patients

Breast Cancer
NCT00780000

Terminated

Clinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast Cancer

Breast Cancer
NCT00003095

Completed

S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer

Breast Cancer
NCT02042456

Terminated

Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening Compared to Full Field Digital Mammography in Women With Dense Breasts

Breast Cancer
NCT00203372

Completed

Neoadjuvant TAC Plus or Minus Bevacizumab(AVF3299)

Breast Cancer
NCT01985841

Terminated

Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer

Breast Cancer
NCT01047358

Completed

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer

Breast Cancer
NCT00530751

Withdrawn

Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation

Breast Cancer
NCT00779129

Completed

A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948)

Breast Neoplasm

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations